Wang Ya-Dong, Wu Ling-Ling, Ma Lu-Yuan, Shang Xiao-Bo, Li Zi-Yue, Wang Wei, Shen Chuan, Yang Jing-Jing, Sun Li-Xia, Zhao Cai-Yan
Department of Infectious Diseases, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang.
Department of Infectious Diseases, Nanpi County Hospital, Cangzhou.
Medicine (Baltimore). 2019 Jan;98(2):e14032. doi: 10.1097/MD.0000000000014032.
Chronic active Epstein-Barr virus infection (CAEBV) is a common infectious disease that often affects multiple organs or systems. However, it is liable to be neglected and misdiagnosed owing to its insidious onset, lack of specific findings in the early phase, and a general lack of awareness among clinicians. PATIENT CONCERNS:: a 27-year-old woman case has been described who was initially misdiagnosed as drug-induced liver injury due to onset presentation of mild splenomegaly, recurrent liver dysfunction, and disputable pathological evidence of liver biopsy.
CAEBV complicated with natural killer (NK) cell lymphoma and hemophagocytic lymphohistiocytosis (HLH) was diagnosed by in situ hybridization of liver tissue section with EBV-encoded RNA -1 probe and flow cytometry of bone marrow.
After admission, the patient received symptomatic treatment and antiviral therapy (combination of acyclovir and foscarnet sodium) as well as adjuvant treatment (thymosin alpha 1 and methylprednisolone); later, the patient received etoposide and dexamethasone for diagnosis of EBV associated HLH. Subsequently, the disease progressed to NK cell lymphoma and the patient received the revised EPOCH chemotherapy regimen [etoposide (100 mg/d, d1-5), dexamethasone (7.5 mg/d, d1-5; 5 mg/d, d6-14), cyclophosphamide (0.8 g/d, d1-2), and pegaspargase (3750 u/d, tid, d1-2)].
Although the patient received a series of therapies and other comprehensive measures, finally she died of gastrointestinal hemorrhage and multiple organ failure.
Liver is one of the main target organs of EBV infection. In the clinical setting of unexplained fever and liver injury, it is necessary to be aware of CAEBV, as well as its fatal complication such as EBV associated NK cell lymphoma and HLH.
慢性活动性EB病毒感染(CAEBV)是一种常见的传染病,常累及多个器官或系统。然而,由于其起病隐匿、早期缺乏特异性表现以及临床医生普遍认识不足,该病容易被忽视和误诊。
描述了一名27岁女性病例,该患者最初因轻度脾肿大、反复肝功能异常以及肝活检病理证据存在争议而被误诊为药物性肝损伤。
通过肝组织切片原位杂交检测EB病毒编码RNA -1探针以及骨髓流式细胞术,诊断为CAEBV合并自然杀伤(NK)细胞淋巴瘤和噬血细胞性淋巴组织细胞增生症(HLH)。
入院后,患者接受了对症治疗、抗病毒治疗(阿昔洛韦和膦甲酸钠联合使用)以及辅助治疗(胸腺肽α1和甲泼尼龙);之后,患者接受依托泊苷和地塞米松治疗以诊断EB病毒相关HLH。随后,疾病进展为NK细胞淋巴瘤,患者接受了修订的EPOCH化疗方案[依托泊苷(100mg/d,第1 - 5天)、地塞米松(7.5mg/d,第1 - 5天;5mg/d,第6 - 14天)、环磷酰胺(0.8g/d,第1 - 2天)和聚乙二醇天冬酰胺酶(3750u/d,每日三次,第1 - 2天)]。
尽管患者接受了一系列治疗及其他综合措施,但最终死于消化道出血和多器官功能衰竭。
肝脏是EB病毒感染的主要靶器官之一。在不明原因发热和肝损伤的临床情况下,有必要警惕CAEBV及其致命并发症,如EB病毒相关NK细胞淋巴瘤和HLH。